Alvotech(ALVO)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Pending next ranking run
This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
ALVO Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Alvotech (ALVO), a Healthcare sector company. ALVO is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Top institutional holders of ALVO by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, Bracebridge Capital,, MILLENNIUM MANAGEMENT, based on the most recent SEC filings. ALVO trades on the Nasdaq exchange and files with the SEC under CIK 1898416. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ALVO daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Alvotech directly from SEC EDGAR.
Get alerted when ALVO's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Alvotech including:
Top Institutional Holders of ALVO
VANGUARD CAPITAL MANAGEMENT LLC
$11.8M3,410,447 shBracebridge Capital, LLC
$9.3M2,705,304 shMILLENNIUM MANAGEMENT LLC
$7.3M2,122,596 shLITTLEJOHN & CO LLC
$4.5M1,318,534 shBlackRock, Inc.
$4.3M1,245,195 shVANGUARD FIDUCIARY TRUST CO
$3.4M974,228 shLegal & General Group Plc
$1.7M504,460 shOAKTREE CAPITAL MANAGEMENT LP
$1.3M4,669,508 shGEODE CAPITAL MANAGEMENT, LLC
$1.1M324,199 shUBS Group AG
$1.1M322,157 sh
| Fund | Value | Shares |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $11.8M | 3,410,447 |
| Bracebridge Capital, LLC | $9.3M | 2,705,304 |
| MILLENNIUM MANAGEMENT LLC | $7.3M | 2,122,596 |
| LITTLEJOHN & CO LLC | $4.5M | 1,318,534 |
| BlackRock, Inc. | $4.3M | 1,245,195 |
| VANGUARD FIDUCIARY TRUST CO | $3.4M | 974,228 |
| Legal & General Group Plc | $1.7M | 504,460 |
| OAKTREE CAPITAL MANAGEMENT LP | $1.3M | 4,669,508 |
| GEODE CAPITAL MANAGEMENT, LLC | $1.1M | 324,199 |
| UBS Group AG | $1.1M | 322,157 |
More Healthcare Companies
View all Healthcare →Put ALVO on your watchlist
Track score changes the day Alvotech files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is ALVO a good stock to buy?
13F Pro's AI-powered analysis of Alvotech (ALVO) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ALVO are available on the ALVO stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own ALVO?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ALVO. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Alvotech's investment landscape.